
Updated NEO100 Phase 1/2a results and NEO212 Phase 1 data to be presented at the Society for Neuro-Oncology Annual Meeting on November 13 CALABASAS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced financial results for the third quarter ended September 30, 2026, and highlighted recent corporate and clinica
Third Quarter 2026 Net Revenues of $6.23 Million, Gross Profit of $3.50 Million and Gross Margin of 56.2% Net Revenue Increase of 429% and Gross Profit Increase of 481% as Compared to Q3 of the Prior Year Backlog of $28.3M of Awarded Firm-Fixed Price Orders Going into the Fourth Quarter of 2026 REDMOND, Wash., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), an AI software company that turns the video, sensor and enterprise data organiza
newsCOLUMBUS, Ohio, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its third quarter 2026 financial results before market open on Thursday, November 19, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Tom Javitch, interim chief financial officer, will discuss the company's results and provide a business update. Supplemental materials wi

Management Board of Baltic Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the nine months of 2026. Net profit for the nine months to 30 September 2026 was EUR 6,903 thousand, compared with a loss of EUR 959 thousand a year earlier. Excluding revaluations, nine-month net profit was EUR 2,151 thousand (2025: loss of EUR 946 thousand). Quarterly net rental income rose by about a third to EUR 3,478 thousand (Q3 2025: EUR 2,631 thousand). The rev
Updated NEO100 Phase 1/2a results and NEO212 Phase 1 data to be presented at the Society for Neuro-Oncology Annual Meeting on November 13 CALABASAS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced financial results for the third quarter ended September 30, 2026, and highlighted recent corporate and clinica
newsThird Quarter 2026 Net Revenues of $6.23 Million, Gross Profit of $3.50 Million and Gross Margin of 56.2% Net Revenue Increase of 429% and Gross Profit Increase of 481% as Compared to Q3 of the Prior Year Backlog of $28.3M of Awarded Firm-Fixed Price Orders Going into the Fourth Quarter of 2026 REDMOND, Wash., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), an AI software company that turns the video, sensor and enterprise data organiza

Updated NEO100 Phase 1/2a results and NEO212 Phase 1 data to be presented at the Society for Neuro-Oncology Annual Meeting on November 13 CALABASAS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced financial results for the third quarter ended September 30, 2026, and highlighted recent corporate and clinica
Third Quarter 2026 Net Revenues of $6.23 Million, Gross Profit of $3.50 Million and Gross Margin of 56.2% Net Revenue Increase of 429% and Gross Profit Increase of 481% as Compared to Q3 of the Prior Year Backlog of $28.3M of Awarded Firm-Fixed Price Orders Going into the Fourth Quarter of 2026 REDMOND, Wash., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), an AI software company that turns the video, sensor and enterprise data organiza
newsCOLUMBUS, Ohio, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its third quarter 2026 financial results before market open on Thursday, November 19, 2026. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which Daniel Heaf, chief executive officer, and Tom Javitch, interim chief financial officer, will discuss the company's results and provide a business update. Supplemental materials wi

Updated NEO100 Phase 1/2a results and NEO212 Phase 1 data to be presented at the Society for Neuro-Oncology Annual Meeting on November 13 CALABASAS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced financial results for the third quarter ended September 30, 2026, and highlighted recent corporate and clinica
Third Quarter 2026 Net Revenues of $6.23 Million, Gross Profit of $3.50 Million and Gross Margin of 56.2% Net Revenue Increase of 429% and Gross Profit Increase of 481% as Compared to Q3 of the Prior Year Backlog of $28.3M of Awarded Firm-Fixed Price Orders Going into the Fourth Quarter of 2026 REDMOND, Wash., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), an AI software company that turns the video, sensor and enterprise data organiza
newsBALTIMORE, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today reported financial results for third quarter 2026. (1) Third Quarter 2026 Highlights (1) Billings for the third quarter 2026 totaled $80.7 million, representing a 27% year-over-year increase compared to the third quarter

Updated NEO100 Phase 1/2a results and NEO212 Phase 1 data to be presented at the Society for Neuro-Oncology Annual Meeting on November 13 CALABASAS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced financial results for the third quarter ended September 30, 2026, and highlighted recent corporate and clinica
Third Quarter 2026 Net Revenues of $6.23 Million, Gross Profit of $3.50 Million and Gross Margin of 56.2% Net Revenue Increase of 429% and Gross Profit Increase of 481% as Compared to Q3 of the Prior Year Backlog of $28.3M of Awarded Firm-Fixed Price Orders Going into the Fourth Quarter of 2026 REDMOND, Wash., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), an AI software company that turns the video, sensor and enterprise data organiza
news- Completed the Halneuron ® Phase 2b trial in Chemotherapy Induced Neuropathy, top-line results to be announced in November 2026 - - Phase 2b Long-Term Extension Study fully recruited, 95 patients enrolled, assessing Halneuron ® reduction in pain over three months of treatment with Halneuron ® - - Closed $5M Private Placement with Sealbond Limited, a subsidiary of CK Life Sciences Int’l., (Holdings) Inc., to Advance Phase 3 Preparatory Activities - ALPHARETTA, Ga., Nov. 05, 2026 (GLOBE NEWSWIRE)
Growth is being redefined. Expanding revenue remains important, but businesses are placing greater emphasis on profitability, cash discipline, operational efficiency, customer retention and resilience. This edition explores the changing growth playbook and the foundations required for sustainable expansion. From technology and process design to capital allocation and market reach, it examines how businesses can pursue ambition without allowing complexity, costs or uncontrolled expansion to weaken the enterprise.
For years, growth was often discussed primarily in terms of size, speed and market share. The conversation is becoming more balanced. Strong businesses also need healthy economics, efficient operations and the ability to withstand uncertainty. This edition looks at growth through that wider lens and considers how organizations can expand with greater discipline, clarity and long-term purpose in practice.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.